跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,154 条关于
“Ataxia Telangiectasia”
全部
1,154
临床试验
812
药物
47
机构
37
资讯
258
8个月前
IntraBio's Levacetylleucine Achieves Primary Endpoint in Pivotal Phase III Trial for Ataxia-Telangiectasia
去年
Quince Therapeutics Secures Up to $22 Million to Advance Phase 3 Ataxia-Telangiectasia Trial
去年
IntraBio Completes Phase III Recruitment for Ataxia-Telangiectasia Treatment in Record Time
去年
Liquid Fat Supplement Shows Promise in Treating Rare Childhood Disease Ataxia-Telangiectasia
去年
Quince Therapeutics' Phase 3 NEAT Trial for Ataxia-Telangiectasia Reaches 50% Enrollment Milestone
10个月前
Quince Therapeutics Receives Positive Safety Review for Ataxia-Telangiectasia Treatment in Phase 3 Trial
2个月前
Niagen Bioscience Launches NB4168, a Proprietary NAD+ Precursor, as First Pharmaceutical Candidate for Ataxia Telangiectasia
去年
Quince Therapeutics' EryDex Phase 3 Trial for Ataxia-Telangiectasia Nears Enrollment Completion
去年
EryDex Shows Long-Term Safety in Pediatric Ataxia-Telangiectasia Patients
去年
Quince Therapeutics Presents Phase 3 ATTeST Trial Safety Data for EryDex in Ataxia-Telangiectasia
第 1 页,共 26 页
上一页
下一页